Please Wait.....
Report
Australia and New Zealand Healthcare CROs Market Report and Forecast 2025-2034
Market Report I 2025-07-29 I 200 Pages I EMR Inc.
The Australia and New Zealand healthcare CROs market size was valued at USD 1.12 Billion in 2024, driven by the rising awareness about the advantages of CROs across the globe. The market size is anticipated to grow at a CAGR of 12.10% during the forecast period of 2025-2034 to achieve a value of USD 3.51 Billion by 2034.
Healthcare CROs: Introduction
In the field of life sciences, contract research organization (CRO) is a company that outsource their research services on a contract basis to pharmaceutical, biotechnology, and medical device organizations. The services provided by CRO may include biopharmaceutical development, biological assay development, commercialization, clinical development, clinical trials management, pharmacovigilance, and research outcomes.
CROs are designed to be cost effective for companies that are developing new medicines and drugs in specified healthcare markets. The major purpose of a CRO is to simplify entry of other pharmaceutical or biotechnology companies into drug markets and simplify the development process of drugs for them in accordance with their requirement. CROs also help foundations, universities, and research institutions with governmental organizations, such as the NIH and EMA, among others. Many CROs certainly provide clinical-study and clinical-trial support for drugs and/or medical devices as well.
Australia and New Zealand Healthcare CROs Market Analysis
The increasing practices of outsourcing of services by pharmaceutical and biotechnology companies in Australia and New Zealand to reduce their expenditure upon the possession of equipment and their maintenance is a major factor influencing the market growth. The increasing demand for oncology research in countries is driving the Australia and New Zealand healthcare CROs market growth. The increasing prevalence of cancer in the countries is justifying the rising demand of oncology research in the countries as there is a surging demand for personalized treatment on the market. The increasing digitization of CROs in Australia and New Zealand is also supporting the increasing demand.
Australia and New Zealand Healthcare CROs Market Segmentations
Australia and New Zealand Healthcare CROs Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Phase Type
- Drug Discovery
- Preclinical
- Clinical
Market Breakup by Indication
- Oncology
- Cardiovascular
- Autoimmune/Inflammation
- Central Nervous System (CNS)
- Dermatology
- Infectious Diseases
- Respiratory
- Others
Australia and New Zealand Healthcare CROs Market Overview
The increasing adoption of advanced technologies in the healthcare sector of Australia and New Zealand is contributing to the market growth. The market is witnessing significant growth and is expected to keep growing in coming years as well. This market growth is supported by the rising strategic initiatives such as geographical expansions of CROs. The increasing collaborations among key players in the market are also expected to drive the market growth. The continuous research and development activities are also contributing to the market expansion. The cost-effectiveness which is provided by the CROs and favourable environment for clinical trials as they are equipped with all the necessary requirements for such purposes are a few key factors among others, boosting the for Australia and New Zealand Healthcare CROs market demand.
The revenue growth in the healthcare contract research organizations has also been boosted by the adoption of virtual clinical trials which is most in action since pandemic. The adoption of virtual technologies to streamline clinical research services by CROs is also expected to justify the market growth. The significant advancements taking place in the market to speed up and update the clinical trials is expected to escalate the market growth.
Australia and New Zealand Healthcare CROs Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- PAREXEL International Corporation
- Thermo Fischer Scientific, Inc.
- SGS SA
- ICON plc
- Medpace Australia Pty. Ltd
- Charles River Laboratories International, Inc.
- IQVIA
- Novotech
- Laboratory Corporation of America Holdings
- Syneos Health
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Australia and New Zealand Healthcare CROs Market Overview
3.1 Australia and New Zealand Healthcare CROs Market Historical Value (2018-2024)
3.2 Australia and New Zealand Healthcare CROs Market Forecast Value (2025-2034)
4 Australia and New Zealand Healthcare CROs Market Landscape
4.1 Lentiviral Vectors: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Lentiviral Vectors: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
5 Australia and New Zealand Healthcare CROs Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter's Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Australia and New Zealand Healthcare CROs Market Segmentation
6.1 Australia and New Zealand Healthcare CROs Market by Phase Type
6.1.1 Market Overview
6.1.2 Drug Discovery
6.1.3 Preclinical
6.1.4 Clinical
6.2 Australia and New Zealand Healthcare CROs Market by Indication
6.2.1 Market Overview
6.2.2 Oncology
6.2.3 Cardiovascular
6.2.4 Autoimmune/Inflammation
6.2.5 Central Nervous System (CNS)
6.2.6 Dermatology
6.2.7 Infectious Diseases
6.2.8 Respiratory
6.2.9 Others
7 Australia and New Zealand Healthcare CROs Market
7.1 Market Share by Country
7.2 Australia
7.3 New Zealand
8 Funding and Investment Analysis
8.1 Analysis by Funding Instances
8.2 Analysis by Type of Funding
8.3 Analysis by Funding Amount
8.4 Analysis by Leading Players
8.5 Analysis by Leading Investors
8.6 Analysis by Geography
9 Partnership and Collaborations Analysis
9.1 Analysis by Partnership Instances
9.2 Analysis by Type of Partnership
9.3 Analysis by Leading Players
9.4 Analysis by Geography
10 Supplier Landscape
10.1 PAREXEL International Corporation
10.1.1 Financial Analysis
10.1.2 Product Portfolio
10.1.3 Demographic Reach and Achievements
10.1.4 Mergers and Acquisitions
10.1.5 Certifications
10.2 Thermo Fischer Scientific, Inc.
10.2.1 Financial Analysis
10.2.2 Product Portfolio
10.2.3 Demographic Reach and Achievements
10.2.4 Mergers and Acquisitions
10.2.5 Certifications
10.3 SGS SA
10.3.1 Financial Analysis
10.3.2 Product Portfolio
10.3.3 Demographic Reach and Achievements
10.3.4 Mergers and Acquisitions
10.3.5 Certifications
10.4 ICON plc
10.4.1 Financial Analysis
10.4.2 Product Portfolio
10.4.3 Demographic Reach and Achievements
10.4.4 Mergers and Acquisitions
10.4.5 Certifications
10.5 Medpace Australia Pty. Ltd
10.5.1 Financial Analysis
10.5.2 Product Portfolio
10.5.3 Demographic Reach and Achievements
10.5.4 Mergers and Acquisitions
10.5.5 Certifications
10.6 Charles River Laboratories International, Inc.
10.6.1 Financial Analysis
10.6.2 Product Portfolio
10.6.3 Demographic Reach and Achievements
10.6.4 Mergers and Acquisitions
10.6.5 Certifications
10.7 IQVIA
10.7.1 Financial Analysis
10.7.2 Product Portfolio
10.7.3 Demographic Reach and Achievements
10.7.4 Mergers and Acquisitions
10.7.5 Certifications
10.8 Novotech
10.8.1 Financial Analysis
10.8.2 Product Portfolio
10.8.3 Demographic Reach and Achievements
10.8.4 Mergers and Acquisitions
10.8.5 Certifications
10.9 Laboratory Corporation of America Holdings
10.9.1 Financial Analysis
10.9.2 Product Portfolio
10.9.3 Demographic Reach and Achievements
10.9.4 Mergers and Acquisitions
10.9.5 Certifications
10.10 Syneos Health
10.10.1 Financial Analysis
10.10.2 Product Portfolio
10.10.3 Demographic Reach and Achievements
10.10.4 Mergers and Acquisitions
10.10.5 Certifications
11 Key Opinion Leaders (KOL) Insights (Additional Insight)
12 Company Competitiveness Analysis (Additional Insight)
12.1 Very Small Companies
12.2 Small Companies
12.3 Mid-Sized Companies
12.4 Large Companies
12.5 Very Large Companies
13 Payment Methods (Additional Insight)
13.1 Government Funded
13.2 Private Insurance
13.3 Out-of-Pocket
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security